Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KIF11 | P52732 | 1/20 | 0.41 |
| ▸ | CHRNA7 | P36544 | 5/20 | 0.40 |
| ▸ | F2RL3 | Q96RI0 | 1/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | NISCH | Q9Y2I1 | 1/20 | 0.38 |
| ▸ | HCRTR1 | O43613 | 4/20 | 0.38 |
| ▸ | HCRTR2 | O43614 | 4/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.38 |
| ▸ | SCN5A | Q14524 | 2/20 | 0.37 |
| ▸ | SCN1A | P35498 | 1/20 | 0.37 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.37 |
| ▸ | SCN9A | Q15858 | 1/20 | 0.37 |
| ▸ | SCN2A | Q99250 | 1/20 | 0.37 |
| ▸ | SCN8A | Q9UQD0 | 1/20 | 0.37 |
| ▸ | SCN10A | Q9Y5Y9 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2084265 | 0.77 | KIF11 (0.53) | KIF11CHRNA7L3MBTL1 | |
| SCHEMBL7732525 | 0.76 | CHRNA7 (0.33) | CHRNA7NISCHHCRTR1HCRTR2NPSR1 | |
| SCHEMBL30366911 | 0.74 | KIF11 (0.40) | KIF11NISCHNPSR1SCN5ASCN1A | |
| SCHEMBL30046979 | 0.74 | AKR1C2 (0.44) | KIF11NISCHSCN5ASCN1ASCN2A | |
| SCHEMBL514500 | 0.74 | CA1 (0.58) | CHRNA7L3MBTL1 | |
| SCHEMBL28716842 | 0.73 | MAOB (0.41) | KIF11CHRNA7NISCHSCN5ASCN1A | |
| SCHEMBL7730614 | 0.73 | FAAH (0.38) | — | |
| SCHEMBL29936641 | 0.72 | EPHX2 (0.45) | KIF11L3MBTL1NPSR1SCN10A | |
| SCHEMBL2056112 | 0.72 | CHRNA7 (0.49) | KIF11CHRNA7L3MBTL1 | |
| SCHEMBL23041015 | 0.71 | KIF11 (0.41) | KIF11NISCHSCN5ASCN1AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11492360-B2 | Organic compound and electroluminescent device containing the same | Beijing Summer Sprout Technology Co., Ltd. (CN) | 2022-11-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11492360-B2 | Organic compound and electroluminescent device containing the same | OCIAD1, OCIAD2, SLCO4C1 | KIF11 1906/4885CHRNA7 1846/4885F2RL3 4827/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.